The global Pentavalent Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Lyophilized Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pentavalent Vaccine include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, Crucell and Bio Farma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
This report aims to provide a comprehensive presentation of the global market for Pentavalent Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pentavalent Vaccine. This report contains market size and forecasts of Pentavalent Vaccine in global, including the following market information:
Global Pentavalent Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pentavalent Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pentavalent Vaccine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pentavalent Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pentavalent Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pentavalent Vaccine Market Segment Percentages, by Type, 2022 (%)
Lyophilized
Liquid
Global Pentavalent Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pentavalent Vaccine Market Segment Percentages, by Application, 2022 (%)
Retail Pharmacy
Hospital Pharmacy
E-commerce
Global Pentavalent Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pentavalent Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pentavalent Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pentavalent Vaccine revenues share in global market, 2022 (%)
Key companies Pentavalent Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pentavalent Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Serum Institute of India
Panacea Drugs Pvt. Ltd
Shantha Biotechnics
Biological E. Ltd.
Novartis AG
Crucell
Bio Farma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pentavalent Vaccine, market overview.
Chapter 2: Global Pentavalent Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Pentavalent Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pentavalent Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pentavalent Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Pentavalent Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pentavalent Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pentavalent Vaccine Overall Market Size
2.1 Global Pentavalent Vaccine Market Size: 2022 VS 2029
2.2 Global Pentavalent Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pentavalent Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Pentavalent Vaccine Players in Global Market
3.2 Top Global Pentavalent Vaccine Companies Ranked by Revenue
3.3 Global Pentavalent Vaccine Revenue by Companies
3.4 Global Pentavalent Vaccine Sales by Companies
3.5 Global Pentavalent Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pentavalent Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pentavalent Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pentavalent Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pentavalent Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pentavalent Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pentavalent Vaccine Market Size Markets, 2022 & 2029
4.1.2 Lyophilized
4.1.3 Liquid
4.2 By Type - Global Pentavalent Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pentavalent Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Pentavalent Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Pentavalent Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Pentavalent Vaccine Sales & Forecasts
4.3.1 By Type - Global Pentavalent Vaccine Sales, 2018-2023
4.3.2 By Type - Global Pentavalent Vaccine Sales, 2024-2029
4.3.3 By Type - Global Pentavalent Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Pentavalent Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pentavalent Vaccine Market Size, 2022 & 2029
5.1.2 Retail Pharmacy
5.1.3 Hospital Pharmacy
5.1.4 E-commerce
5.2 By Application - Global Pentavalent Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pentavalent Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Pentavalent Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Pentavalent Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Pentavalent Vaccine Sales & Forecasts
5.3.1 By Application - Global Pentavalent Vaccine Sales, 2018-2023
5.3.2 By Application - Global Pentavalent Vaccine Sales, 2024-2029
5.3.3 By Application - Global Pentavalent Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Pentavalent Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Pentavalent Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Pentavalent Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pentavalent Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Pentavalent Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Pentavalent Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Pentavalent Vaccine Sales & Forecasts
6.3.1 By Region - Global Pentavalent Vaccine Sales, 2018-2023
6.3.2 By Region - Global Pentavalent Vaccine Sales, 2024-2029
6.3.3 By Region - Global Pentavalent Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Pentavalent Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Pentavalent Vaccine Sales, 2018-2029
6.4.3 US Pentavalent Vaccine Market Size, 2018-2029
6.4.4 Canada Pentavalent Vaccine Market Size, 2018-2029
6.4.5 Mexico Pentavalent Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Pentavalent Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Pentavalent Vaccine Sales, 2018-2029
6.5.3 Germany Pentavalent Vaccine Market Size, 2018-2029
6.5.4 France Pentavalent Vaccine Market Size, 2018-2029
6.5.5 U.K. Pentavalent Vaccine Market Size, 2018-2029
6.5.6 Italy Pentavalent Vaccine Market Size, 2018-2029
6.5.7 Russia Pentavalent Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Pentavalent Vaccine Market Size, 2018-2029
6.5.9 Benelux Pentavalent Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Pentavalent Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Pentavalent Vaccine Sales, 2018-2029
6.6.3 China Pentavalent Vaccine Market Size, 2018-2029
6.6.4 Japan Pentavalent Vaccine Market Size, 2018-2029
6.6.5 South Korea Pentavalent Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Pentavalent Vaccine Market Size, 2018-2029
6.6.7 India Pentavalent Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Pentavalent Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Pentavalent Vaccine Sales, 2018-2029
6.7.3 Brazil Pentavalent Vaccine Market Size, 2018-2029
6.7.4 Argentina Pentavalent Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pentavalent Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Pentavalent Vaccine Sales, 2018-2029
6.8.3 Turkey Pentavalent Vaccine Market Size, 2018-2029
6.8.4 Israel Pentavalent Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Pentavalent Vaccine Market Size, 2018-2029
6.8.6 UAE Pentavalent Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Serum Institute of India
7.1.1 Serum Institute of India Company Summary
7.1.2 Serum Institute of India Business Overview
7.1.3 Serum Institute of India Pentavalent Vaccine Major Product Offerings
7.1.4 Serum Institute of India Pentavalent Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Serum Institute of India Key News & Latest Developments
7.2 Panacea Drugs Pvt. Ltd
7.2.1 Panacea Drugs Pvt. Ltd Company Summary
7.2.2 Panacea Drugs Pvt. Ltd Business Overview
7.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Major Product Offerings
7.2.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Panacea Drugs Pvt. Ltd Key News & Latest Developments
7.3 Shantha Biotechnics
7.3.1 Shantha Biotechnics Company Summary
7.3.2 Shantha Biotechnics Business Overview
7.3.3 Shantha Biotechnics Pentavalent Vaccine Major Product Offerings
7.3.4 Shantha Biotechnics Pentavalent Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Shantha Biotechnics Key News & Latest Developments
7.4 Biological E. Ltd.
7.4.1 Biological E. Ltd. Company Summary
7.4.2 Biological E. Ltd. Business Overview
7.4.3 Biological E. Ltd. Pentavalent Vaccine Major Product Offerings
7.4.4 Biological E. Ltd. Pentavalent Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Biological E. Ltd. Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Pentavalent Vaccine Major Product Offerings
7.5.4 Novartis AG Pentavalent Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Crucell
7.6.1 Crucell Company Summary
7.6.2 Crucell Business Overview
7.6.3 Crucell Pentavalent Vaccine Major Product Offerings
7.6.4 Crucell Pentavalent Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Crucell Key News & Latest Developments
7.7 Bio Farma
7.7.1 Bio Farma Company Summary
7.7.2 Bio Farma Business Overview
7.7.3 Bio Farma Pentavalent Vaccine Major Product Offerings
7.7.4 Bio Farma Pentavalent Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Bio Farma Key News & Latest Developments
8 Global Pentavalent Vaccine Production Capacity, Analysis
8.1 Global Pentavalent Vaccine Production Capacity, 2018-2029
8.2 Pentavalent Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pentavalent Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pentavalent Vaccine Supply Chain Analysis
10.1 Pentavalent Vaccine Industry Value Chain
10.2 Pentavalent Vaccine Upstream Market
10.3 Pentavalent Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pentavalent Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report